A migraine is not simply a bad headache. It is a complex neurological condition with distinct brain mechanisms, a characteristic set of symptoms beyond head pain, and, in many cases, a progression through multiple phases that can last for days. The most common type of headache people experience, tension-type headache, differs from migraine in where and how it hurts, what is happening inside the nervous system, and how much it disrupts daily life. The confusion between the two is understandable because both involve head pain, but the differences matter for treatment, long-term management, and knowing when something more serious might be going on.
How the Pain Feels
Tension-type headache is typically described as a bilateral, pressing or tightening sensation, often compared to a band squeezing around the head. It tends to settle across the forehead, temples, or back of the skull, and its intensity is mild to moderate. Crucially, it does not usually get worse when you walk, climb stairs, or bend over.
Migraine pain behaves differently. It is usually moderate to severe, often pulsating or throbbing, and it is classically one-sided. That said, roughly 40 percent of people with migraine report pain on both sides, and only about a quarter have strictly one-sided headaches every time.
1PubMed Central. Debate: differences and similarities between tension-type headache and migraineOne of the most reliable distinguishing features is that migraine pain worsens with routine physical activity. If bending forward to pick something up or walking up a flight of stairs intensifies the pain, that strongly points toward migraine rather than tension-type headache.
Beyond the pain itself, migraine brings along companions that tension-type headache usually does not. Nausea and vomiting are common during migraine attacks. Sensitivity to light (photophobia) and sound (phonophobia) can become so severe that people retreat to dark, quiet rooms. These associated symptoms are part of the diagnostic criteria for migraine and help clinicians tell the two apart even when the headache location or quality overlaps.
The Phases of a Migraine Attack
A tension-type headache is relatively straightforward. Pain builds, persists for hours, and resolves. A migraine attack, by contrast, often unfolds across four phases, though not everyone experiences all of them.
The prodrome, sometimes called the premonitory phase, can begin hours or even a day or two before the headache itself. People may notice fatigue, mood shifts, unusual food cravings, excessive yawning, or difficulty concentrating. Research points to the hypothalamus as the driver of these early symptoms, with neuroimaging studies showing hypothalamic activation during the premonitory phase and neurotransmitters like dopamine and orexin playing a role in generating the characteristic yawning and cravings.
2PubMed Central. The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidenceFor about a quarter to a third of people with migraine, an aura phase follows. Aura involves temporary neurological symptoms, most commonly visual disturbances such as shimmering zigzag lines, blind spots, or flashing lights. Some people experience tingling or numbness that spreads up one arm and into the face, and a smaller number have difficulty speaking. These symptoms build gradually over minutes and typically resolve within an hour. They are driven by a phenomenon called cortical spreading depression, a slow wave of intense nerve cell activity followed by a period of electrical silence that sweeps across the brain’s surface.
3PubMed Central. Migrainous Infarction and Cortical Spreading DepressionAfter the headache phase resolves, many people experience a postdrome or “migraine hangover” that can last another day. They feel drained, foggy, or mildly confused, sometimes with lingering sensitivity to light. Tension-type headache has nothing comparable to this multi-day progression.
What Is Happening in the Brain
The underlying biology of migraine and tension-type headache involves different systems. Migraine is now understood as a neurological disorder, not primarily a vascular problem as scientists once thought. A key player is the trigeminovascular system, the network of trigeminal nerve fibers that wraps around blood vessels in the brain’s protective membranes. When this system activates during a migraine, it releases a neuropeptide called calcitonin gene-related peptide, or CGRP. CGRP triggers a cascade of events including inflammation around the meningeal blood vessels and sensitization of pain-processing nerves.
4PubMed Central. CGRP and the Trigeminal System in MigraineDuring active migraine attacks, CGRP levels rise measurably in the blood draining from the skull, and injecting CGRP intravenously can trigger migraine-like symptoms in people who are prone to the condition.
5PubMed. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in MigraineTension-type headache appears to involve different pathways. In its chronic form, heightened tenderness in the muscles around the skull, known as pericranial muscles, is a prominent feature. Research has found that people with chronic tension-type headache have significantly more pericranial muscle tenderness than people without headaches, and this tenderness exists independently of headache frequency or severity, suggesting it may be present early in the condition’s development rather than simply being a result of frequent pain.
1PubMed Central. Debate: differences and similarities between tension-type headache and migraineUnderstanding the trigeminovascular system and CGRP’s role in migraine has been transformative for treatment. The discovery led to an entirely new class of medications: monoclonal antibodies that target CGRP or its receptor, and small-molecule CGRP receptor blockers called gepants. These treatments are specific to migraine and have no role in tension-type headache, which underscores how biologically distinct the two conditions are.
6PubMed Central. Migraine and the trigeminovascular system-40 years and countingWhy Migraine Gets Misdiagnosed
One of the most common diagnostic mix-ups is not between migraine and tension-type headache but between migraine and sinus headache. Migraine often causes congestion, sinus pressure, and even a runny nose, because the same trigeminal nerve system that drives migraine pain also activates autonomic responses in the face. People feel the pain around their cheeks, forehead, and eyes, notice a stuffy nose, and reasonably conclude they have a sinus headache.
7PubMed Central. Migraine misdiagnosis as a sinusitis, a delay that can last for many yearsHeadache specialists consider true sinus headache to be relatively rare, yet it is one of the most frequently self-diagnosed and physician-diagnosed conditions. Studies have found that a high proportion of patients diagnosed with sinus headache actually meet the diagnostic criteria for migraine.
8PubMed. Sinus headache or migraine? Considerations in making a differential diagnosisThe practical cost of this misdiagnosis is significant. People spend years treating recurrent “sinus infections” with decongestants and antibiotics that do nothing for the underlying migraine, missing out on treatments that could actually help. If you get recurring headaches with sinus-like symptoms but no fever and no thick, discolored nasal discharge, migraine is a more likely explanation than sinusitis.
The cranial autonomic symptoms that create this confusion, including tearing, eyelid swelling, and facial flushing, can also mimic cluster headache, another headache disorder. In migraine, though, these autonomic symptoms tend to be bilateral, mild to moderate in intensity, and inconsistent from one attack to the next, whereas in cluster headache they are typically one-sided, severe, and reliably present on the same side as the pain.
9Journal of Neurology, Neurosurgery & Psychiatry. Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headacheWho Gets Which and Why
Tension-type headache is the most common headache disorder worldwide, and it affects men and women at roughly similar rates across age groups. Migraine is different. It predominantly affects women between the ages of roughly 15 and 49, and forecasting models suggest its prevalence will continue to grow without targeted public health intervention.
10PubMed Central. An analysis of the burden of migraine and tension-type headache across the global, China, the United States, India and JapanThe gender gap in migraine is driven in large part by hormones. Estrogen fluctuations are a well-documented migraine trigger. The most-discussed theory is the estrogen withdrawal hypothesis: migraine attacks tend to coincide with the natural drop in estrogen levels that occurs just before menstruation. Women with a history of migraine appear more sensitive to these physiological fluctuations than women who do not get migraines.
11PubMed Central. The complex relationship between estrogen and migraines: a scoping reviewThis hormonal connection explains why migraine often starts around puberty, can change dramatically during pregnancy, and frequently improves after menopause.
Genetics also play a clear role. Migraine runs in families, and genome-wide studies have identified more than 180 genetic variants associated with increased susceptibility. Each individual variant contributes only a small increase in risk, but collectively they form networks of molecular abnormalities, primarily in neuronal and vascular pathways, that lower the threshold for an attack.
12PubMed Central. Genetics of migraine: where are we now?People with familial migraine carry a higher genetic load from common polygenic variation than those with non-familial migraine, and the load is even higher in migraine with aura.
13PubMed Central. Advance in genetics of migraineTriggers and Lifestyle
Stress is the single most widely recognized migraine trigger, with over 90 percent awareness among migraine patients in one recent study. Sleep-related issues ranked second. Around 40 percent of people with migraine were aware of specific food triggers, though the actual role of individual foods in migraine is debated and highly individual.
14PubMed Central. Migraine triggers and lifestyle modifications: an assessment of patients’ awareness and the role of healthcare providers in patient educationA frustrating finding from that same study: while about two-thirds of participants said their doctors had discussed lifestyle changes for migraine management, fewer than 30 percent were actively managing their triggers. The gap between knowing your triggers and consistently acting on that knowledge is one of the biggest real-world challenges in migraine care. Behavioral interventions, including cognitive behavioral therapy, relaxation training, and mindfulness-based approaches, have shown the ability to reduce migraine frequency and disability in clinical trials, though the overall evidence is still graded as low certainty.
15PubMed Central. Behavioral interventions for migraine prevention: A systematic review and meta-analysisTension-type headache responds to lifestyle adjustments too, but its triggers tend to be simpler. Sustained postures, eye strain, and stress are common culprits, and the condition usually improves with basic ergonomic changes, stretching, and over-the-counter pain relievers.
The Medication Overuse Trap
One way a headache can morph into something worse is through medication overuse. When pain relievers, whether over-the-counter analgesics or prescription migraine drugs, are used too frequently, the brain can adapt in ways that actually lower its pain threshold. The result is medication overuse headache, a cycle where the treatment itself perpetuates the problem. Several mechanisms have been proposed for how this happens, including sensitization of pain pathways from repeated activation, direct interference with the brain’s built-in pain-suppression systems, and changes in serotonin signaling.
16PubMed. Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and managementThis is relevant to both migraine and tension-type headache, but migraine patients are at higher risk because they are more likely to use acute medications frequently. The general rule of thumb is that using acute headache medications on more than 10 to 15 days per month can put you at risk, depending on the medication type. If you find yourself reaching for pain relief this often, it is worth talking to a doctor about preventive treatment rather than continuing to treat each attack individually.
When a Headache Is Something Else Entirely
Both migraine and tension-type headache are classified as primary headache disorders, meaning the headache itself is the condition rather than a symptom of another problem. Secondary headaches, where the pain signals an underlying disease, are less common but more dangerous. Clinicians use a set of warning signs, known as red flags, to decide when a headache needs urgent investigation.
Key red flags include:
- Thunderclap onset: A headache that reaches maximum intensity within seconds, which can signal a brain hemorrhage.
- New headache after age 65: First-ever headaches in older adults are more likely to have a secondary cause.
- Pattern change: A headache that feels fundamentally different from your usual pattern.
- Neurological signs: Weakness, confusion, seizures, or loss of consciousness accompanying the headache.
- Systemic symptoms: Fever, weight loss, or night sweats alongside headache.
- Positional component: Pain that dramatically worsens when lying down or standing up.
- Post-traumatic onset: A new headache pattern following a head injury.
None of these red flags by themselves guarantee a dangerous diagnosis, but any of them warrants medical evaluation rather than self-treatment. The distinction between primary and secondary headache is more important than the distinction between migraine and tension-type headache, because secondary headaches can be life-threatening.
18PubMed Central. Secondary headaches – red and green flags and their significance for diagnosticsThe Workplace and Quality-of-Life Gap
The functional impact of the two conditions is starkly different. People with migraine lose significantly more productive work time and report lower quality of life compared to those with tension-type headache alone.
19PubMed Central. Disability, quality of life, productivity impairment and employer costs of migraine in the workplaceA study of information technology workers in Korea put numbers on the gap: the estimated total annual economic loss per person from migraine was around five times higher than that from tension-type headache, driven primarily by “presenteeism,” the phenomenon of being at work but functioning poorly rather than being absent altogether.
20PubMed Central. Disability and Economic Loss Caused by Headache among Information Technology Workers in KoreaThis matters because migraine disproportionately strikes people during their most productive years. The combination of high prevalence in working-age women and substantial per-person disability means migraine has an outsized economic and social footprint relative to how seriously it is sometimes taken.
Migraine With Aura and Stroke Risk
One consequence unique to migraine, and specifically to migraine with aura, is a modest but real increase in the risk of ischemic stroke. A study of young women found that those with probable migraine with visual aura had about 1.5 times the odds of ischemic stroke compared to women without migraine.
21PubMed. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women studyThe risk climbed sharply when combined with smoking and oral contraceptive use: women with migraine with aura who both smoked and used oral contraceptives had about seven times the odds of stroke compared to those with migraine with aura who did neither.
In absolute terms, the risk of stroke in young women remains low, so even a sevenfold increase translates to a small absolute number. But the finding has practical implications. If you have migraine with aura, your doctor may recommend against combined estrogen-containing contraceptives and will strongly encourage quitting smoking. Tension-type headache carries no equivalent vascular risk.
22PubMed Central. Migraine: migraine with aura increases the risk of strokeMigraine Without the Headache
The assumption that migraine always means head pain is itself a misconception. Migraine aura can occur without any headache at all, a phenomenon sometimes called “silent migraine” or “acephalgic migraine.” People experience the visual disturbances, tingling, or speech difficulties but never develop the head pain phase. This is more common in older adults and can be alarming because the symptoms resemble a stroke or transient ischemic attack.
In children, migraine can present as recurrent abdominal pain rather than headache. Abdominal migraine affects roughly 0.2 to 4 percent of children and involves episodes of moderate-to-severe belly pain accompanied by pallor, nausea, and sometimes light sensitivity. Between episodes, the children feel completely fine. Many of these children go on to develop typical migraine with headache as they get older.
23PubMed Central. Review of Abdominal Migraine in ChildrenNewer Treatment Approaches
The treatment landscape for migraine has expanded considerably beyond traditional painkillers and triptans. The CGRP-targeting drugs mentioned earlier represent the biggest shift: monoclonal antibodies given by injection monthly or quarterly for prevention, and gepants taken as pills to either prevent or treat individual attacks. A separate class, the ditans, target a specific serotonin receptor subtype and offer an option for people who cannot use triptans because of cardiovascular risk.
24PubMed Central. Revisiting Migraine: The Evolving Pathophysiology and the Expanding Management ArmamentariumDevice-based treatments are also gaining ground. Non-invasive vagus nerve stimulation, delivered through a handheld device held against the neck, has shown some benefit for acute migraine treatment. In one randomized trial, pain freedom at 30 minutes was about three times more likely with active stimulation than with a sham device. A meta-analysis of stimulation applied to the ear rather than the neck found it could reduce migraine days by about two per month.
25PubMed Central. Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study26PubMed Central. Noninvasive vagus nerve stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials
Cognitive behavioral therapy has also demonstrated meaningful effects on migraine frequency and disability scores, and it carries essentially no side-effect risk, making it a useful complement to medication for people who want to reduce their pill burden.
27PubMed Central. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-AnalysisTension-type headache, by contrast, rarely requires this level of therapeutic sophistication. Over-the-counter analgesics, stress management, and physical therapy handle most cases. The gulf in treatment complexity mirrors the gulf in underlying biology and reflects just how different these two conditions really are beneath the shared label of “headache.”